Ich stimme der Verwendung von Cookies zu. Auch wenn ich diese Website weiter nutze, gilt dies als Zustimmung.

Bitte lesen und akzeptieren Sie die Datenschutzinformation und Cookie-Informationen, damit Sie unser Angebot weiter nutzen können. Natürlich können Sie diese Einwilligung jederzeit widerrufen.






21st Austria weekly - Valneva, Erste Group (16/06/2022)

19.06.2022

Valneva: Valneva, an Austrian/French specialty vaccine company, today announced that it has entered into a settlement agreement with the Government of the United Kingdom (“HMG”) in relation to the termination of the supply agreement for Valneva’s COVID-19 vaccine candidate, VLA2001. The Company announced on September 13, 2021 that it had received a termination notice from HMG, and the termination, which Valneva accepted on the basis of HMG’s discretionary right to terminate for convenience, became effective on October 10, 2021. The settlement agreement resolves certain matters relating to the obligations of the Company and HMG following the termination of the supply agreement and in relation to the separate agreement relating to clinical trials of VLA2001 in the United Kingdom, which remains in place. The Company continues to have certain other obligations pursuant to provisions of the supply agreement that survive its termination.
Valneva: weekly performance: -24.04%

Erste Group: At an extraordinary meeting, the Supervisory Board of Erste Group appointed Willi Cernko as the new CEO of Erste Group Bank AG effective 1 July 2022. As CEO, Cernko succeeds Bernd Spalt, who had previously announced that he would not seek a renewal of his contract. Cernko will also assume the function of Chief Retail Officer for the banking group. His position as the Chief Corporates Officer at Erste Bank Oesterreich will be filled.
Erste Group: weekly performance: -4.36%

(From the 21st Austria weekly https://www.boerse-social.com/21staustria (16/06/2022)


Partners









latest 21st Austria

21st Austria weekly - Valneva, Erste Group (16/06/2022)


19.06.2022, 1555 Zeichen



Valneva: Valneva, an Austrian/French specialty vaccine company, today announced that it has entered into a settlement agreement with the Government of the United Kingdom (“HMG”) in relation to the termination of the supply agreement for Valneva’s COVID-19 vaccine candidate, VLA2001. The Company announced on September 13, 2021 that it had received a termination notice from HMG, and the termination, which Valneva accepted on the basis of HMG’s discretionary right to terminate for convenience, became effective on October 10, 2021. The settlement agreement resolves certain matters relating to the obligations of the Company and HMG following the termination of the supply agreement and in relation to the separate agreement relating to clinical trials of VLA2001 in the United Kingdom, which remains in place. The Company continues to have certain other obligations pursuant to provisions of the supply agreement that survive its termination.
Valneva: weekly performance: -24.04%

Erste Group: At an extraordinary meeting, the Supervisory Board of Erste Group appointed Willi Cernko as the new CEO of Erste Group Bank AG effective 1 July 2022. As CEO, Cernko succeeds Bernd Spalt, who had previously announced that he would not seek a renewal of his contract. Cernko will also assume the function of Chief Retail Officer for the banking group. His position as the Chief Corporates Officer at Erste Bank Oesterreich will be filled.
Erste Group: weekly performance: -4.36%

(From the 21st Austria weekly https://www.boerse-social.com/21staustria (16/06/2022)



BSN Podcasts
Christian Drastil: Wiener Börse Plausch

SportWoche Podcast S1/12: Plausch mit Alexandra Baldessarini über Hundesport und Sport mit Hunden




 

Bildnachweis

Aktien auf dem Radar:Flughafen Wien, AT&S, voestalpine, Warimpex, Addiko Bank, Immofinanz, Semperit, UBM, BTV AG, Bawag, Frequentis, Kostad, Lenzing, Mayr-Melnhof, OMV, Porr, Polytec Group, Rosenbauer, Wolford, Oberbank AG Stamm, BKS Bank Stamm, RHI Magnesita, S Immo, Symrise, Beiersdorf, Sartorius, Qiagen, Deutsche Boerse, Siemens Healthineers, Bayer, Daimler.


Random Partner

Valneva
Valneva ist ein Impfstoffunternehmen, das sich auf die Entwicklung und Vermarktung von prophylaktischen Impfstoffen gegen Infektionskrankheiten mit hohem ungedeckten medizinischen Bedarf spezialisiert hat.

>> Besuchen Sie 62 weitere Partner auf boerse-social.com/partner


Useletter

Die Useletter "Morning Xpresso" und "Evening Xtrakt" heben sich deutlich von den gängigen Newslettern ab. Beispiele ansehen bzw. kostenfrei anmelden. Wichtige Börse-Infos garantiert.

Newsletter abonnieren

Runplugged

Infos über neue Financial Literacy Audio Files für die Runplugged App
(kostenfrei downloaden über http://runplugged.com/spreadit)

per Newsletter erhalten